Found: 143
Select item for more details and to access through your institution.
Low-dose titrated amitriptyline as second-line treatment for adults with irritable bowel syndrome in primary care: the ATLANTIS RCT.
- Published in:
- Health Technology Assessment, 2024, v. 28, n. 65-67, p. 1, doi. 10.3310/BFCR7986
- By:
- Publication type:
- Article
Current Guidelines for Dyspepsia Management.
- Published in:
- Digestive Diseases, 2008, v. 26, n. 3, p. 225, doi. 10.1159/000121351
- By:
- Publication type:
- Article
Infliximab Therapeutic Drug Monitoring in Inflammatory Bowel Disease Virtual Biologics Clinic Leads to Durable Clinical Results.
- Published in:
- Inflammatory Intestinal Diseases, 2021, v. 6, n. 3, p. 132, doi. 10.1159/000515593
- By:
- Publication type:
- Article
Multiple myeloma presenting in association with gastric phytobezoar.
- Published in:
- Clinical Case Reports, 2017, v. 5, n. 9, p. 1493, doi. 10.1002/ccr3.1104
- By:
- Publication type:
- Article
Ethnicity, Gender, and Socioeconomic Status as Risk Factors for Esophagitis and Barrett's Esophagus.
- Published in:
- American Journal of Epidemiology, 2005, v. 162, n. 5, p. 454, doi. 10.1093/aje/kwi218
- By:
- Publication type:
- Article
Antibiotics and Probiotics for Irritable Bowel Syndrome.
- Published in:
- Drugs, 2023, v. 83, n. 8, p. 687, doi. 10.1007/s40265-023-01871-y
- By:
- Publication type:
- Article
Beliefs about management of irritable bowel syndrome in primary care: cross-sectional survey in one locality.
- Published in:
- Primary Health Care Research & Development, 2015, v. 16, n. 3, p. 263, doi. 10.1017/S1463423614000383
- By:
- Publication type:
- Article
Anxiety and Depression Increase in a Stepwise Manner in Parallel With Multiple FGIDs and Symptom Severity and Frequency.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2015, v. 110, n. 7, p. 1038, doi. 10.1038/ajg.2015.128
- By:
- Publication type:
- Article
Lack of Utility of Symptoms and Signs at First Presentation as Predictors of Inflammatory Bowel Disease in Secondary Care.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2015, v. 110, n. 5, p. 716, doi. 10.1038/ajg.2015.117
- By:
- Publication type:
- Article
Reducing the Need for Random Colonic Biopsies in Patients With Diarrhea.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2015, v. 110, n. 2, p. 351, doi. 10.1038/ajg.2014.401
- By:
- Publication type:
- Article
Efficacy of Prebiotics, Probiotics, and Synbiotics in Irritable Bowel Syndrome and Chronic Idiopathic Constipation: Systematic Review and Meta-analysis.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2014, v. 109, n. 10, p. 1547, doi. 10.1038/ajg.2014.202
- By:
- Publication type:
- Article
The Effect of Fiber Supplementation on Irritable Bowel Syndrome: A Systematic Review and Meta-analysis.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2014, v. 109, n. 9, p. 1367, doi. 10.1038/ajg.2014.195
- By:
- Publication type:
- Article
Effect of Antidepressants and Psychological Therapies, Including Hypnotherapy, in Irritable Bowel Syndrome: Systematic Review and Meta-Analysis.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2014, v. 109, n. 9, p. 1350, doi. 10.1038/ajg.2014.148
- By:
- Publication type:
- Article
American College of Gastroenterology Monograph on the Management of Irritable Bowel Syndrome and Chronic Idiopathic Constipation.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2014, v. 109, p. S2, doi. 10.1038/ajg.2014.187
- By:
- Publication type:
- Article
Polyethylene Glycol in Constipation-Predominant Irritable Bowel Syndrome.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2014, v. 109, n. 1, p. 135, doi. 10.1038/ajg.2013.389
- By:
- Publication type:
- Article
Response to Neis et al.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2013, v. 108, n. 12, p. 1930, doi. 10.1038/ajg.2013.338
- By:
- Publication type:
- Article
Efficacy of Pharmacological Therapies for the Treatment of Opioid-Induced Constipation: Systematic Review and Meta-Analysis.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2013, v. 108, n. 10, p. 1566, doi. 10.1038/ajg.2013.169
- By:
- Publication type:
- Article
Efficacy of Oral, Topical, or Combined Oral and Topical 5-Aminosalicylates, in Ulcerative Colitis: Systematic Review and Network Meta-analysis.
- Published in:
- Journal of Crohn's & Colitis, 2021, v. 15, n. 7, p. 1184, doi. 10.1093/ecco-jcc/jjab010
- By:
- Publication type:
- Article
Ciclosporin or Infliximab as Rescue Therapy in Acute Glucorticosteroid-Refractory Ulcerative Colitis: Systematic Review and Network Meta-Analysis.
- Published in:
- Journal of Crohn's & Colitis, 2021, v. 15, n. 5, p. 733, doi. 10.1093/ecco-jcc/jjaa226
- By:
- Publication type:
- Article
Systematic Review and Network Meta-Analysis of Medical Therapies to Prevent Recurrence of Post-Operative Crohn's Disease.
- Published in:
- Journal of Crohn's & Colitis, 2019, v. 13, n. 6, p. 693, doi. 10.1093/ecco-jcc/jjy216
- By:
- Publication type:
- Article
Long-term Efficacy and Safety of Azathioprine in Ulcerative Colitis.
- Published in:
- Journal of Crohn's & Colitis, 2015, v. 9, n. 2, p. 191, doi. 10.1093/ecco-jcc/jju010
- By:
- Publication type:
- Article
Pharmacotherapy for Irritable Bowel Syndrome.
- Published in:
- Journal of Clinical Medicine, 2017, v. 6, n. 11, p. 101, doi. 10.3390/jcm6110101
- By:
- Publication type:
- Article
General practitioners' perceptions of irritable bowel syndrome: a Q-methodological study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Novel symptom clusters predict disease impact and healthcare utilisation in inflammatory bowel disease: Prospective longitudinal follow‐up study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 11/12, p. 1163, doi. 10.1111/apt.17735
- By:
- Publication type:
- Article
Editorial: Recognising the regional variations in profile of irritable bowel syndrome—better late than never! Authors' reply.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
A prospective comparison of UK and Malaysian patients with irritable bowel syndrome in secondary care.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 2, p. 168, doi. 10.1111/apt.17567
- By:
- Publication type:
- Article
Letter: determining priorities for patients with faecal incontinence and irritable bowel syndrome—authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 1, p. 139, doi. 10.1111/apt.17571
- By:
- Publication type:
- Article
Randomised, placebo‐controlled trial and meta‐analysis show benefit of ondansetron for irritable bowel syndrome with diarrhoea: The TRITON trial.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 11, p. 1258, doi. 10.1111/apt.17426
- By:
- Publication type:
- Article
Does irritable bowel syndrome have a greater impact in Western, compared with Asian, patients? Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 10, p. 1190, doi. 10.1111/apt.17497
- By:
- Publication type:
- Article
faecal incontinence is prevalent in IBS, as are effective treatment options! Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 10, p. 1176, doi. 10.1111/apt.17494
- By:
- Publication type:
- Article
Prevalence and impact of faecal incontinence among individuals with Rome IV irritable bowel syndrome.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 10, p. 1083, doi. 10.1111/apt.17465
- By:
- Publication type:
- Article
Editorial: definition of factors associated with poor quality of life in patients with IBS—but where to from here? Authorsʼ reply.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Systematic review with network meta‐analysis: Risk of Herpes zoster with biological therapies and small molecules in inflammatory bowel disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 6, p. 666, doi. 10.1111/apt.17379
- By:
- Publication type:
- Article
Factors associated with lower disease‐specific and generic health‐related quality of life in Rome IV irritable bowel syndrome.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 3, p. 323, doi. 10.1111/apt.17356
- By:
- Publication type:
- Article
Natural history and impact of irritable bowel syndrome‐type symptoms in inflammatory bowel disease during 6 years of longitudinal follow‐up.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 8, p. 1264, doi. 10.1111/apt.17193
- By:
- Publication type:
- Article
Editorial: natural history of irritable bowel syndrome in inflammatory bowel disease—authors' reply.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Letter: efficacy of peppermint oil in irritable bowel syndrome—authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 7, p. 1217, doi. 10.1111/apt.17197
- By:
- Publication type:
- Article
Systematic review and meta‐analysis: efficacy of peppermint oil in irritable bowel syndrome.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 6, p. 932, doi. 10.1111/apt.17179
- By:
- Publication type:
- Article
Editorial: work and activity impairment are important considerations to optimise treatment plans for irritable bowel syndrome. Authors' reply.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Impact of Rome IV irritable bowel syndrome on work and activities of daily living.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 5, p. 844, doi. 10.1111/apt.17132
- By:
- Publication type:
- Article
Direct healthcare costs of Rome IV or Rome III‐defined irritable bowel syndrome in the United Kingdom.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 1, p. 110, doi. 10.1111/apt.16939
- By:
- Publication type:
- Article
Editorial: estimating the costs of care in irritable bowel syndrome—a necessary step to enhance value‐based care for a high‐prevalence, low‐cost condition. Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 12, p. 1590, doi. 10.1111/apt.16966
- By:
- Publication type:
- Article
Willingness to accept risk with medication in return for cure of symptoms among patients with Rome IV irritable bowel syndrome.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 10, p. 1311, doi. 10.1111/apt.16816
- By:
- Publication type:
- Article
Editorial: risky business. What do sufferers' perceptions of risk from interventions for IBS really mean? Authors' reply.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Sarcopenia, severe anxiety and increased C-reactive protein are associated with severe fatigue in patients with inflammatory bowel diseases.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-94685-5
- By:
- Publication type:
- Article
Review: Prevention and management of gastric cancer.
- Published in:
- Helicobacter, 2020, v. 25, p. 1, doi. 10.1111/hel.12740
- By:
- Publication type:
- Article
Epidemiology of Helicobacter pylori infection and Public Health Implications.
- Published in:
- Helicobacter, 2010, v. 15, n. S1, p. 1, doi. 10.1111/j.1523-5378.2010.00779.x
- By:
- Publication type:
- Article
IBS-like symptoms in patients with ulcerative colitis.
- Published in:
- Clinical & Experimental Gastroenterology, 2015, v. 8, p. 101, doi. 10.2147/CEG.S58153
- By:
- Publication type:
- Article
Testing for Celiac Disease in Patients With Symptoms of Irritable Bowel Syndrome.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Will the History and Physical Examination Help Establish That Irritable Bowel Syndrome Is Causing This Patient's Lower Gastrointestinal Tract Symptoms?
- Published in:
- JAMA: Journal of the American Medical Association, 2008, v. 300, n. 15, p. 1793, doi. 10.1001/jama.300.15.1793
- By:
- Publication type:
- Article